The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.
Bahn
Rebecca S
RS
Burch
Henry S
HS
Cooper
David S
DS
Garber
Jeffrey R
JR
Greenlee
Carol M
CM
Klein
Irwin L
IL
Laurberg
Peter
P
McDougall
I Ross
IR
Rivkees
Scott A
SA
Ross
Douglas
D
Sosa
Julie Ann
JA
Stan
Marius N
MN
D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced; D008713:Methimazole / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011441:Propylthiouracil / Q000009:adverse effects / Q000627:therapeutic use*; D012955:Societies, Medical; D014481:United States; D014486:United States Food and Drug Administration
D013956:Antithyroid Agents; D008713:Methimazole; D011441:Propylthiouracil